Funds with similar focus
Fund Name | Location |
9F Group | Beijing, Beijing, China |
Chesapeake Partners Management | Bethesda, Maryland, United States |
CityBlock Capital | New York, New York, United States |
Dquadat Equity Partner | - |
FDNC SFS | - |
Fininvest | Italy, Lazio, Rome |
HASE | China, Guangdong, Shenzhen |
Humphrey Enterprises LLC | Boston, Massachusetts, United States |
Jinpengjia Holdings | - |
Leaf Clean Energy | District of Columbia, United States, Washington |
LID Group | Florida, Miami, United States |
Louisiana Technology Innovation Fund | Baton Rouge, Louisiana, United States |
Nordic Angel Fund | - |
Pobox | - |
Pod Investment | Stockholm, Stockholm County, Sweden |
Redgate Partners | California, United States, Whittier |
Samch Capital | China, Shanghai |
SI Securities, LLC | - |
SNCF | France, Ile-de-France, Saint-denis-lès-rebais |
Stellaris Venture Partners | Bangalore, India, Karnataka |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Taichu Biotechnology | 01 Jul 2022 | Shanghai, Shanghai, China | |||
NuProbe | $42M | 11 Jan 2021 | Boston, Massachusetts, United States | ||
BioNova Pharma | $25M | 20 Oct 2020 | Shanghai | ||
Exegenesis Bio | 03 Aug 2020 | Pennsylvania, United States | |||
LaNova Medicines | 01 Jul 2020 | Shanghai, Shanghai, China | |||
Tisenc | $12M | 14 Jan 2020 | Futian District, Guangdong Province, China | ||
$12M | 01 Jan 2019 | Shanghai, China | |||
Zion Pharma | $2M | 01 May 2018 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Taichu Biotechnology | 01 Jul 2022 | Shanghai, Shanghai, China | |||
NuProbe | $42M | 11 Jan 2021 | Boston, Massachusetts, United States | ||
BioNova Pharma | $25M | 20 Oct 2020 | Shanghai | ||
Exegenesis Bio | 03 Aug 2020 | Pennsylvania, United States | |||
LaNova Medicines | 01 Jul 2020 | Shanghai, Shanghai, China | |||
Tisenc | $12M | 14 Jan 2020 | Futian District, Guangdong Province, China | ||
$12M | 01 Jan 2019 | Shanghai, China | |||
Zion Pharma | $2M | 01 May 2018 | Shanghai, China |